Literature DB >> 8877626

Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations.

C H Hinkin1, W G van Gorp, P Satz, T Marcotte, R S Durvasula, S Wood, L Campbell, M R Baluda.   

Abstract

The relationship between subjective awareness and objective neuropsychological status in HIV-1 infection remains unclear. Forty-six HIV-1 seropositive males were administered a battery of neuropsychological measures assessing episodic memory, metacognition, and depression. Results of ANOVA revealed a dissociation between subjects' self-complaint of neuropsychological impairment and objective performance, with subjects who denied cognitive impairment performing worse on memory testing. Three subgroups were identified: A group whose self-reported cognitive impairment exceeded deficits demonstrated on memory testing (37% of subjects); a group who denied impairment but evidenced deficits on memory testing (26% of subjects); and a group whose self-appraisal was consistent with performance (37% of subjects). These data suggest that self-report of cognitive dysfunction among HIV-1 infected subjects is frequently at variance with objective neuropsychological testing and that diminished awareness of decline among medically symptomatic HIV-1 infected subjects can be identified.

Entities:  

Mesh:

Year:  1996        PMID: 8877626     DOI: 10.1080/01688639608408999

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  30 in total

1.  The human immunodeficiency virus reduces network capacity: acoustic noise effect.

Authors:  Dardo Tomasi; Linda Chang; Elisabeth de Castro Caparelli; Frank Telang; Thomas Ernst
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

2.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

Review 3.  Metamemory experiments in neurological populations: a review.

Authors:  Jasmeet K Pannu; Alfred W Kaszniak
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

4.  Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV.

Authors:  Steven Paul Woods; Catherine L Carey; Lisa M Moran; Matthew S Dawson; Scott L Letendre; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2007-02-06       Impact factor: 2.813

Review 5.  Neuropsychological evaluation of everyday memory.

Authors:  M Perez Garcia; J F Godoy Garcia; N Vera Guerrero; J A Laserna Triguero; A E Puente
Journal:  Neuropsychol Rev       Date:  1998-12       Impact factor: 7.444

6.  Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.

Authors:  Stephanie Chiao; Howard J Rosen; Krista Nicolas; Lauren A Wendelken; Oscar Alcantar; Katherine P Rankin; Bruce Miller; Victor Valcour
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-20       Impact factor: 2.205

7.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

8.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

Review 9.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

10.  Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study.

Authors:  Monique M Cherrier; Paul R Borghesani; Amy L Shelton; Celestia S Higano
Journal:  BMC Cancer       Date:  2010-01-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.